Forskning ved Københavns Universitet - Københavns Universitet

Forside

Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Karsten Zieger
  • Lars Dyrskjøt
  • Wiuf, Carsten
  • Jens L. Jensen
  • Claus L. Andersen
  • Klaus Møller Ernst Jensen
  • Torben Falck Ørntoft

Purpose: Bladder tumors develop through different molecular pathways. Recent reports suggest activating mutations of the fibroblast growth factor receptor 3 (FGFR3) gene as marker for the "papillary" pathway with good prognosis, in contrast to the more malignant "carcinoma in situ" (CIS) pathway. The aim of this clinical follow-up study was to investigate the role of FGFR3 mutations in bladder cancer development in a longitudinal study. Experimental Design: We selected 85 patients with superficial bladder tumors, stratified into early (stage Ta/grade 1-2, n = 35) and more advanced (either stage T1 or grade 3, n = 50) developmental stages. The patients were followed prospectively, and metachronous tumors were included. We did screening for FGFR3 and TP53 mutations by direct bidirectional sequencing and for genome-wide molecular changes with microarray technology. Results: A total of 43 of 85 cases (51%) showed activating mutations of FGFR3. The mutations were associated with papillary tumors of early developmental stage. However, after stratifying for developmental stage, FGFR3-mutated tumors showed the same malignant potential as wild-type tumors. Tumors with concomitant CIS were generally FGFR3 wild type. They were characterized by different patterns of chromosomal changes and gene expression signatures compared with FGFR3-mutated tumors, indicating different molecular pathways. Conclusions: FGFR3 mutations seem to have a central role in the early development of papillary bladder tumors. These tumors follow a common molecular pathway, which is different from tumors with concomitant CIS. FGFR3 mutations do not seem to play a role in bladder cancer progression.

OriginalsprogEngelsk
TidsskriftClinical Cancer Research
Vol/bind11
Udgave nummer21
Sider (fra-til)7709-7719
Antal sider11
ISSN1078-0432
DOI
StatusUdgivet - 1 nov. 2005
Eksternt udgivetJa

ID: 203902255